The 35th CINP World Congress of Neuropsychopharmacology

Session information

[CINP2024] Poster Session

CINP2024 » Poster Session

Schizophrenia 3 - Clinical (2)

Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)

*Yuki Yamamoto1, Genichi Sugihara1, Masaaki Shimizu1, Takahiko Kawashima2, Ayumu Yamashita3,6, Yujiro Yoshihara2, Junichiro Yoshimoto3,8, Jun Miyata2,4, Toshiya Murai2, Mitsuo Kawato3,7, Ming-Chyi Huang9,10, Hidehiko Takahashi1,5 (1. Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 2. Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3. Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institutes International (ATR), Kyoto, Japan, 4. Department of Psychiatry, Aichi Medical University, Aichi, Japan, 5. Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan, 6. Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan, 7. XNef Incorporation, Kyoto, Japan, 8. Department of Biomedical Data Science, School of Medicine, Fujita Health University, Aichi, Japan, 9. Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 10. Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei, Taiwan)

*Pin-Yen Lu1, Yu-Lien Huang6, Kao-Chin Chen2, Po-See Chen2,3,4, Yen-Kuang Yang2,3,5, Huai-Hsuan Tseng2,3 (1. Ju Shan Hospital, Taoyuan, Taiwan, 2. Department of Psychiatry, National Cheng Kung University Hospital, Tainan, Taiwan, 3. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 4. Department of Psychiatry, National Cheng Kung University Hospital Dou-Liou Branch, Yunlin, Taiwan, 5. Department of Psychiatry, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan, 6. Department of Psychology, Fo Guang University, Yilan, Taiwan)

*Ryosuke Tarumi1,2, Shiori Honda1, Takahide Etani3,4, Saki Homma3, Yuka Kaneko5, Karin Matsushita1, Sotarou Moriyama1, Yui Tobari1, Fumihiko Ueno1,6, Guillermo Horga7, Clifford Cassidy8, Sakiko Tsugawa1, Hiroyuki Uchida1,6, Ariel GraffGuerrero6, Yoshihiro Noda1,6, Shinichiro Nakajima1,6 (1. Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan, 2. Seikei-Kai Komagino Hospital, Japan, 3. Graduate School of Media and Governance, Keio University, Kanagawa, Japan, 4. School of Medicine, College of Medical, Pharmaceutical, and Health, Kanazawa University, Kanazawa, Japan, 5. Faculty of Policy Manegement, Keio University, Kanagawa, Japan, 6. Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 7. Department of Psychiatry, Columbia University, New York, NY, US, 8. Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada)

*Daichi Sone1,2, Alexandra L Young3, Shunichiro Shinagawa1, Sakiko Tsugawa4, Yusuke Iwata4, Ryosuke Tarumi4, Kamiyu Ogyu4, Shiori Honda4, Ryo Ochi4, Karin Matsushita4, Fumihiko Ueno4, Nobuaki Hondo4, Akihiro Koreki4, Edgardo Torres-Carmona5, Wanna Mar5, Nathan Chan5, Teruki Koizumi4, Hideo Kato4, Keisuke Kusudo4, Vincenzo de Luca5, Philip Gerretsen5, Gary Remington5, Mitsumoto Onaya4, Yoshihiro Noda4, Hiroyuki Uchida4, Masaru Mimura4, Masahiro Shigeta1, Ariel Graff-Guerrero5, Shinichiro Nakajima4 (1. Jikei University School of Medicine, 2. UCL Queen Square Institute of Neurology, 3. KIng's College London, 4. Keio University School of Medicine, 5. University of Toronto)

*Yuka Yasuda1, Satsuki Ito1, Junya Matsumoto1, Naohiro Okada1, Masaki Fukunaga1, Kiyotaka Nemoto1, Kenichiro Miura1, Naoki Hashimoto1, Kazutaka Ohi1, Tsutomu Takahashi1, Michihiko Koeda1, Hidenaga Yamamori1, Michiko Fujimoto1, Naomi Hasegawa1, Shinsuke Koike1, Motoaki Nakamura1, Go Okada1, Jun Miyata1, Shusuke Numata1, Toshiaki Onitsuka1, Reiji Yoshimura1, Shin Nakagawa1, Yoshiyuki Watanabe1, Norio Ozaki1, Ryota Hashimoto1 (1. National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan)

*Tzuhan Tseng1, Wei-Fen Ma2,3, Hsien-Yuan Lane4,5,6,7, Cheng-Hao Tu8 (1. School of Chinese medicine, China medical university, Taichung, Taiwan, 2. Department of Nursing, China Medical University Hospital, Taichung, Taiwan, 3. School of Nursing, China Medical University Hospital, Taichung, Taiwan, 4. The Brain Disease Research Center, China Medical University Hospital, Taichung, Taiwan, 5. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, 6. Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan, 7. Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung, Taiwan, 8. Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan)

*Edgardo Torres-Carmona1, Fumihiko Ueno1, Yusuke Iwata2, Shinichiro Nakajima2, Jianmeng Song2, Wanna Mar1, Ali Abdolizadeh1, Sri Mahavir Agarwal1, Vincenzo de Luca1, Gary Remington1, Philip Gerretsen1, Ariel Graff-Guerrero1 (1. Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada, 2. Department of Neuropsychiatry, Keio University, Minato, Tokyo, Japan, MD)

*Saeko Ikai-Tani1,2,3, Saki Kamiyma2,4, Hideaki Tani2, Hiroyuki Uchida2 (1. Department of Psychiatry, Minami-Hanno Hospital, Saitama, Japan, 2. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 3. Faculty of Kinesiology & Physical Education, University of Toronto, Toronto, ON, Canada, 4. Department of Psychiatry, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan)

*Naomi Hasegawa1, Yuka Yasuda2,1, Norio Yasui-Furukori3, Hikaru Hori4, Kayo Ichihashi5, Yoshikazu Takaesu6, Hitoshi Iida4, Hiroyuki Muraoka7, Fumitoshi Kodaka8, Junya Matsumoto1, Kenichiro Miura1, Ken Inada7, Koichiro Watanabe9, Ryota Hashimoto1 (1. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Life Grow Brilliant Mental Clinic, Medical Corporation Foster, Osaka, Japan, 3. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 4. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan, 5. Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan, 6. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan, 7. Department of Psychiatry, Kitasato University, School of Medicine, Kanagawa, Japan, 8. Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan, 9. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan)

*Maite Arribas1, Dominic Oliver1,2,3,4, Rashmi Patel5, Daisy Kornblum6, Hitesh Shetty6, Stefano Damiani7, Kamil Krakowski1,7, Umberto Provenzani7, Daniel Stahl6,9, Nikolaos Koutsouleris8,10,11, Philip McGuire2,3,4, Paolo Fusar-Poli1,6,7,12 (1. Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK, 2. Department of Psychiatry, University of Oxford, Oxford, UK, 3. NIHR Oxford Health Biomedical Research Centre, Oxford, UK, 4. OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, UK, 5. Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK, 6. NIHR Maudsley Biomedical Research Centre, London, UK, 7. Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy, 8. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK, 9. Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, London, UK, 10. Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany, 11. Max-Planck Institute of Psychiatry, Munich, Germany, 12. OASIS Service, South London and Maudsley NHS Foundation Trust, London, UK)

*Alessandro Serretti1, Roberto Rodríguez-Jiménez2,3, Veronica Romero-Ferreiro4, Aggie Nuñez-Doyle2, Chiara Fabbri1, Giuseppe Fanelli1, Mauro Scala1,2 (1. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy, 2. Psychiatry, Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain, 3. CIBERSAM, Madrid, Spain, 4. Universidad Europea de Madrid (UEM), Madrid, Spain)

*Alessandro Serretti1, Roberto Rodríguez-Jiménez2,3, Veronica Romero-Ferreiro4, Aggie Nuñez-Doyle2, Chiara Fabbri1, Giuseppe Fanelli1, Mauro Scala1,2 (1. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy, 2. Psychiatry, Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain, 3. CIBERSAM, Madrid, Spain, 4. Universidad Europea de Madrid (UEM), Madrid, Spain)

*Alessandro Serretti1, Roberto Rodríguez-Jiménez2,3, Veronica Romero-Ferreiro4, Aggie Nuñez-Doyle2, Chiara Fabbri1, Giuseppe Fanelli1, Mauro Scala1,2 (1. Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy, 2. Psychiatry, Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain, 3. CIBERSAM, Madrid, Spain, 4. Universidad Europea de Madrid (UEM), Madrid, Spain)

*Yoshihiro Matsumoto1,2, Nobutaka Ayani1,3, Nozomu Oya1, Riki Kitaoka1, Anri Watanabe1, Hiroko Yoshii4, Yuichi Kitaura6,5, Shinichiro Inoue7, Jin Narumoto1 (1. Kyoto Prefectural University of Medicine, 2. Kyoto Prefectural Mental Health Center, 3. Maizuru Medical Center, 4. Kansai Medical University Medical Center, 5. Kansai Medical University, 6. Matsushita Memorial Hospital, 7. Nimi University)

×

Authentication

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

×

Please log in with your participant account.
» Participant Log In